Alnylam Pharmaceuticals
ALNY
#647
Rank
C$41.87 B
Marketcap
$323.50
Share price
0.89%
Change (1 day)
58.87%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: C$41.87 Billion

As of April 2025 Alnylam Pharmaceuticals has a market cap of C$41.87 Billion. This makes Alnylam Pharmaceuticals the world's 647th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025C$41.87 B-4.94%
2024C$44.04 B38.25%
2023C$31.85 B-19.7%
2022C$39.67 B53.49%
2021C$25.84 B34.25%
2020C$19.25 B14.09%
2019C$16.87 B67.93%
2018C$10.04 B-36.56%
2017C$15.84 B266.89%
2016C$4.31 B-61.14%
2015C$11.11 B27.87%
2014C$8.69 B99.19%
2013C$4.36 B358.01%
2012C$0.95 B168.93%
2011C$0.35 B-15.13%
2010C$0.41 B-46.2%
2009C$0.77 B-37.71%
2008C$1.24 B5.28%
2007C$1.18 B28.13%
2006C$0.92 B207.78%
2005C$0.29 B73.36%
2004C$0.17 B

End of Day market cap according to different sources

On Apr 15th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

C$41.51 Billion
by Nasdaq info icon info icon
C$41.50 Billion
by CompaniesMarketCap info icon info icon
C$41.50 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$2.18 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$83.91 B 100.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.27 B-82.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.58 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.17 B-99.57%๐Ÿ‡บ๐Ÿ‡ธ USA
C$303.89 B 625.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$178.22 B 325.67%๐Ÿ‡ซ๐Ÿ‡ท France
C$21.42 B-48.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel